US EditionWeight-loss drugs may lower cancer risk in people with diabetes, a study suggests
- A study led by Lucas Mavromatis at NYU's Grossman School of Medicine found that GLP-1 drugs lowered obesity-related cancer risk in adults with diabetes.
- Researchers analyzed 170,000 patient records and compared those who took GLP-1 receptor agonists to those who took other diabetes drugs not linked to weight loss.
- After four years, the GLP-1 group had a 7% lower risk of obesity-related cancers and 2,501 new cancer cases versus 2,671 in the comparison group, with effects seen mainly in women.
- Dr. Ernest Hawk, not involved in the study, called for more research to confirm these findings, noting this study cannot establish cause and effect but suggests a connection worth exploring.
- The study, supported by the NIH and shared at the annual meeting of the American Society of Clinical Oncology, suggests that widely used weight-loss medications such as Wegovy and Ozempic may help reduce the risk of certain obesity-related cancers.
72 Articles
72 Articles
MedPage Today
Anti-Aging, Acupuncture and Health NewsStudy Links GLP-1 Drugs to Lower Cancer Risk
(MedPage Today) -- CHICAGO -- In patients with type 2 diabetes and obesity, use of GLP-1 receptor agonists was associated with a lower risk of obesity-related cancers and death from any cause, a target trial emulation study found. In a matched...
Scientists Discover Powerful Anti-Cancer Benefits of Popular Weight Loss Drugs
After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related cancer. New research presented at the European Congress on Obesity (ECO) in Malaga, Spain, and published in the journal eClinicalMedicine, suggests that some widely used weight-loss medications may do more than just help people slim [...]
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests – Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates
Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates Can Weight Loss Drugs Like Wegovy Help Prevent Cancer? New Research Explores the Connection the rising popularity of weight loss drugs like Wegovy, Ozempic, and Zepbound has sparked intense interest, not just for their ability to help individuals shed pounds, but also for their potential impact on overall health. Emerging research is now exploring a […] You c…
GLP-1s may cut cancer risk; Gyre’s stock falls after hepatitis C data and offering
Plus, news about Sanofi, Servier, BioNova, Arcutis, Roche, Satellos Bioscience, Fore Biotherapeutics, Cinclus Pharma and Zentiva: GLP-1 drugs could cut cancer risk: An academic, observational study published Friday ahead of ASCO’s annual meeting found that ...
Coverage Details
Bias Distribution
- 74% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
